COLUMN GROUP L P 13D and 13G filings for NGM Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-05 10:55 am Sale | 2024-04-05 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 1,000 100.000% | -22,078,509 (-100.00%) | Filing |
| 2024-02-26 5:16 pm Unchanged | 2024-02-25 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 22,079,509 26.700% | 0 (Unchanged) | Filing |
| 2023-12-29 4:05 pm Purchase | 2023-12-28 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 22,079,509 26.700% | 1,094,533 (+5.22%) | Filing |
| 2022-06-10 4:14 pm Purchase | 2022-06-01 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 20,984,976 26.500% | 1,951,343 (+10.25%) | Filing |
| 2022-02-03 5:23 pm Purchase | 2022-01-24 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 19,033,633 24.500% | 1,378,422 (+7.81%) | Filing |
| 2020-04-02 06:07 am Purchase | 2020-03-23 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 17,655,211 26.000% | 1,111,314 (+6.72%) | Filing |